当前位置:首页 - 行情中心 - 翰宇药业(300199) - 财务分析 - 现金流量表

翰宇药业

(300199)

  

流通市值:177.62亿  总市值:210.65亿
流通股本:7.45亿   总股本:8.83亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金747,075,774.04305,085,821.46902,928,792.67641,389,780.62
  收到的税费返还3,846,710.221,245,829.7435,987,675.7424,529,820.17
  收到其他与经营活动有关的现金27,633,340.652,691,226.2828,455,561.78133,946,814.91
  经营活动现金流入小计778,555,824.91309,022,877.48967,372,030.19799,866,415.7
  购买商品、接受劳务支付的现金233,323,125.08120,441,679.82299,867,230.65209,603,314.33
  支付给职工以及为职工支付的现金120,421,842.466,105,478.99187,107,281.08142,466,609.18
  支付的各项税费29,852,780.8515,160,750.8842,284,360.8629,890,438.99
  支付其他与经营活动有关的现金89,498,721.7336,883,675.94204,209,649.32147,206,878.01
  经营活动现金流出小计473,096,470.06238,591,585.63733,468,521.91529,167,240.51
  经营活动产生的现金流量净额305,459,354.8570,431,291.85233,903,508.28270,699,175.19
二、投资活动产生的现金流量:
  收回投资收到的现金1,043,894.71-2,549,989.212,558,316.43
  取得投资收益收到的现金2,321,414.89-3,288,131.023,288,131.02
  处置固定资产、无形资产和其他长期资产收回的现金净额374,770310,000430,510478,990
  处置子公司及其他营业单位收到的现金净额--1,854,988.231,454,988.23
  投资活动现金流入小计3,740,079.6310,0008,123,618.467,780,425.68
  购建固定资产、无形资产和其他长期资产支付的现金203,175,188.1177,327,936.48234,353,262.95172,829,608.81
  投资支付的现金10,700,0005,500,000442,850442,850
  投资活动现金流出小计213,875,188.1182,827,936.48234,796,112.95173,272,458.81
  投资活动产生的现金流量净额-210,135,108.51-82,517,936.48-226,672,494.49-165,492,033.13
三、筹资活动产生的现金流量:
  吸收投资收到的现金--100,000100,000
  其中:子公司吸收少数股东投资收到的现金--100,000-
  取得借款收到的现金665,355,817.48581,982,817.481,577,752,645.791,008,500,971.04
  收到其他与筹资活动有关的现金380,209,109.18328,182,803.62250,214,172.2398,500,000
  筹资活动现金流入小计1,045,564,926.66910,165,621.11,828,066,818.021,107,100,971.04
  偿还债务支付的现金695,742,757.72608,704,153.221,637,444,452.361,036,925,075.14
  分配股利、利润或偿付利息支付的现金42,003,071.0422,684,987.7394,837,492.4559,182,309.87
  支付其他与筹资活动有关的现金362,164,525.08254,064,525.08119,747,239.0493,662,382.05
  筹资活动现金流出小计1,099,910,353.84885,453,666.031,852,029,183.851,189,769,767.06
  筹资活动产生的现金流量净额-54,345,427.1824,711,955.07-23,962,365.83-82,668,796.02
四、汇率变动对现金及现金等价物的影响-3,718,791.01-1,487,542.241,481,256.881,935,223.65
五、现金及现金等价物净增加额37,260,028.1511,137,768.2-15,250,095.1624,473,569.69
  加:期初现金及现金等价物余额77,282,74877,282,74892,532,843.1692,532,843.16
  期末现金及现金等价物余额114,542,776.1588,420,516.277,282,748117,006,412.85
补充资料:
  净利润235,639,855.52-34,026,010.77-
  资产减值准备8,114,403.33-31,252,039.51-
  固定资产和投资性房地产折旧62,660,164.24-104,665,002.81-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧62,660,164.24-104,665,002.81-
  无形资产摊销17,485,691.44-27,258,873.69-
  长期待摊费用摊销3,631,440.37-6,291,055.72-
  处置固定资产、无形资产和其他长期资产的损失-1,585,559.54--617,186.97-
  固定资产报废损失225,476.13-33,093.64-
  公允价值变动损失133,524.9--153,724.57-
  财务费用36,869,196.16-98,880,040.88-
  投资损失-65,398,342.27--1,346,384.37-
  递延所得税3,349,397.3-8,449,263.09-
  其中:递延所得税资产减少1,522,682.53-1,885,604.23-
    递延所得税负债增加1,826,714.77-6,563,658.86-
  存货的减少-143,537,353.56--35,968,856.85-
  经营性应收项目的减少-876,480.89--49,509,012.22-
  经营性应付项目的增加145,731,230.26-2,253,971.57-
  现金的期末余额114,542,776.15-77,282,748-
  减:现金的期初余额77,282,748-92,532,843.16-
  现金及现金等价物的净增加额37,260,028.15--15,250,095.16-
公告日期2026-08-212026-04-292026-04-292025-10-30
审计意见(境内)标准无保留意见
TOP↑